Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial
Vinojini Vivekanandam, Michael G. Hanna, Richard J. Barohn, Michael McDermott et al.
Citations
13 citations
Journal
The Lancet Neurology
Topics
Genetic Neurodegenerative Diseases
Field-Weighted Citation Impact (FWCI)
3.49
article
Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial
Vinojini Vivekanandam, Michael G. Hanna, Richard J. Barohn, Michael McDermott, Iwona Skorupinska, Emma Matthews, Dipa Jayaseelan
article en
13 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet NeurologyVol. 23(10)
Institutions
St George's, University of London (GB), University of Rochester Medical Center (US), National Hospital for Neurology and Neurosurgery (GB), University College London (GB), University of Missouri (US)